___

• Adyanthaya, S., & Abhilash, B. (2021). Dry eye disease-are we underselling it? An epidemic in the offing and future management trends. Int J Med Opthamol, 3, 41-43.‏
• Aghbash, P. S., Hemmat, N., Nahand, J. S., Shamekh, A., Memar, M. Y., Babaei, A., & Baghi, H. B. (2021). The role of Th17 cells in viral infections. International Immunopharmacology, 91, 107331.‏
• Akpek, E. K., Bunya, V. Y., & Saldanha, I. J. (2019). Sjögren’s syndrome: more than just dry eye. Cornea, 38(5), 658.‏
• Alharbi, O. O., Beyari, G. M., Saber, W. A., Alotaibi, A. F., Bukannan, A. Y., & Mohamed, Y. N. (2020). Etiology, prevalence, risk factors, and treatment of dry eye disease. Int J Med Develop Countr, 4(1), 137-142.‏).
• Alvarez, F., Al‐Aubodah, T. A., Yang, Y. H., & Piccirillo, C. A. (2020). Mechanisms of TREG cell adaptation to inflammation. Journal of leukocyte biology, 108(2), 559-571.‏
• Baiula, M., & Spampinato, S. (2021). Experimental Pharmacotherapy for Dry Eye Disease: A Review. Journal of experimental pharmacology, 13, 345–358. https://doi.org/10.2147/JEP.S237487).
• Barabino, S., Aragona, P., di Zazzo, A., Rolando, M., & with the contribution of selected ocular surface experts from the Società Italiana di Dacriologia e Superficie Oculare. (2021). Updated definition and classification of dry eye disease: Renewed proposals using the nominal group and Delphi techniques. European Journal of Ophthalmology, 31(1), 42-48.‏)
• Cano, R. L. E., & Lopera, H. D. E. (2013). Introduction to T and B lymphocytes. In Autoimmunity: From Bench to Bedside [Internet]. El Rosario University Press.‏
• Chauhan, S. K., El Annan, J., Ecoiffier, T., Goyal, S., Zhang, Q., Saban, D. R., & Dana, R. (2009). Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. The Journal of Immunology, 182(3), 1247-1252.‏
• Chen, Y., & Dana, R. (2021). Autoimmunity in dry eye disease–An updated review of evidence on effector and memory Th17 cells in disease pathogenicity. Autoimmunity Reviews, 20(11), 102933.‏
• Churov, A. V., Mamashov, K. Y., & Novitskaia, A. V. (2020). Homeostasis and the functional roles of CD4+ Treg cells in aging. Immunology Letters, 226, 83-89.‏
• Clayton, J. A. (2018). Dry eye. New England Journal of Medicine, 378(23), 2212-2223.‏
• De Paiva, C. S., Chotikavanich, S., Pangelinan, S. B., Pitcher, J. 3., Fang, B., Zheng, X., ... & Pflugfelder, S. C. (2009). IL-17 disrupts corneal barrier following desiccating stress. Mucosal immunology, 2(3), 243-253.‏
• De Paiva, C. S., Volpe, E. A., Gandhi, N. B., Zhang, X., Zheng, X., Pitcher III, J. D., ... & Pflugfelder, S. C. (2011). Disruption of TGF-β signaling improves ocular surface epithelial disease in experimental autoimmune keratoconjunctivitis sicca. PloS one, 6(12), e29017.‏
• Deng, G., Song, X., Fujimoto, S., Piccirillo, C. A., Nagai, Y., & Greene, M. I. (2019). Foxp3 post-translational modifications and Treg suppressive activity. Frontiers in immunology, 10, 2486.‏
• Dong, Y., Yang, C., & Pan, F. (2021). Post-translational regulations of Foxp3 in Treg cells and their therapeutic applications. Frontiers in Immunology, 12, 626172.‏
• Donthineni, P. R., Shanbhag, S. S., & Basu, S. (2021, January). An evidence-based strategic approach to prevention and treatment of dry eye disease, a modern global epidemic. In Healthcare (Vol. 9, No. 1, p. 89). MDPI.‏
• Fan, N. W., Dohlman, T. H., Foulsham, W., McSoley, M., Singh, R. B., Chen, Y., & Dana, R. (2021). The role of Th17 immunity in chronic ocular surface disorders. The ocular surface, 19, 157-168.‏
• Fu, R., Jiang, Y., Zhou, J., & Zhang, J. (2019). Rebamipide ophthalmic solution modulates the ratio of T helper cell 17/regulatory T cells in dry eye disease mice. Molecular Medicine Reports, 19(5), 4011-4018.‏
• Ganesalingam, K., Ismail, S., Sherwin, T., & Craig, J. P. (2019). Molecular evidence for the role of inflammation in dry eye disease. Clinical and Experimental Optometry, 102(5), 446-454.‏
• Garcia-Alfaro, P., Garcia, S., Rodriguez, I., & Vergés, C. (2021). Dry eye disease symptoms and quality of life in perimenopausal and postmenopausal women. Climacteric, 24(3), 261-266.‏
• Gomes, J. A., & Santo, R. M. (2019). The impact of dry eye disease treatment on patient satisfaction and quality of life: A review. The Ocular Surface, 17(1), 9-19.‏
• Göschl, L., Scheinecker, C., & Bonelli, M. (2019, May). Treg cells in autoimmunity: from identification to Treg-based therapies. In Seminars in immunopathology (Vol. 41, No. 3, pp. 301-314). Springer Berlin Heidelberg.‏
• Guannan, H., Long, S., Xia, H., Dong, W., & Shaozhen, Z. (2018). Clinical characterisation and cytological study of dry eye in patients with autoimmune disease. J Pak Med Assoc, 68(3), 353-358.‏
• Guo, K., & Zhang, X. (2021). Cytokines that modulate the differentiation of Th17 cells in autoimmune uveitis. Journal of Immunology Research, 2021.‏
• Harrell, C. R., Fellabaum, C., Miloradovic, D., Acovic, A., Miloradovic, D., Markovic, B. S., ... & Volarevic, V. (2021). Therapeutic Potential of „Derived-Multiple Allogeneic Proteins Paracrine Signaling-D-Mapps” in the Treatment of Dry Eye Disease. Serbian Journal of Experimental and Clinical Research.‏
• Hasan, Z. A. (2021). Dry eye syndrome risk factors: A systemic review. Saudi Journal of Ophthalmology, 35(2), 131.‏
• He, X., Liang, B., & Gu, N. (2020). Th17/Treg imbalance and atherosclerosis. Disease Markers, 2020.‏
• Inomata, T., Hua, J., Nakao, T., Shiang, T., Chiang, H., Amouzegar, A., & Dana, R. (2018). Corneal tissue from dry eye donors leads to enhanced graft rejection. Cornea, 37(1), 95.‏
• Kimura, K. (2020). Regulatory T cells in multiple sclerosis. Clinical and Experimental Neuroimmunology, 11(3), 148-155.‏
• Korn, T., & Hiltensperger, M. (2021). Role of IL-6 in the commitment of T cell subsets. Cytokine, 146, 155654.‏
• Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009). IL-17 and Th17 Cells. Annual review of immunology, 27, 485-517.‏
• Krebs, C. F., & Panzer, U. (2018). Plasticity and heterogeneity of Th17 in immune-mediated kidney diseases. Journal of Autoimmunity, 87, 61-68.‏
• Lee, J., Choi, J., Lee, W., Ko, K., & Kim, S. (2015). Dehydrodiconiferyl alcohol (DHCA) modulates the differentiation of Th17 and Th1 cells and suppresses experimental autoimmune encephalomyelitis. Molecular immunology, 68(2), 434-444.‏
• Leonardi, A., Modugno, R. L., & Salami, E. (2021). Allergy and dry eye disease. Ocular immunology and inflammation, 29(6), 1168-1176.‏
• Li, B., Huang, L., Lv, P., Li, X., Liu, G., Chen, Y., ... & Fang, W. (2020). The role of Th17 cells in psoriasis. Immunologic research, 68(5), 296-309.‏
• Li, Y., Li, X., Geng, X., & Zhao, H. (2022). The IL-2A receptor pathway and its role in lymphocyte differentiation and function. Cytokine & Growth Factor Reviews.‏
• Liu, R., Gao, C., Chen, H., Li, Y., Jin, Y., & Qi, H. (2017). Analysis of Th17-associated cytokines and clinical correlations in patients with dry eye disease. PloS one, 12(4), e0173301.‏
• Luckheeram, R. V., Zhou, R., Verma, A. D., & Xia, B. (2012). CD4+ T cells: differentiation and functions. Clinical and developmental immunology, 2012.‏
• Malek, T. R., & Castro, I. (2010). Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity, 33(2), 153-165.‏
• Master, A., Kontzias, A., Huang, L., Huang, W., Tsioulias, A., Zarabi, S., ... & Rigas, B. (2021). The transcriptome of rabbit conjunctiva in dry eye disease: Large-scale changes and similarity to the human dry eye. Plos one, 16(7), e0254036.‏
• Matos, T. R., Hirakawa, M., Alho, A. C., Neleman, L., Graca, L., & Ritz, J. (2021). Maturation and Phenotypic Heterogeneity of Human CD4+ Regulatory T Cells From Birth to Adulthood and After Allogeneic Stem Cell Transplantation. Frontiers in immunology, 11, 570550.‏
• Miao, J., & Zhu, P. (2018). Functional defects of Treg cells: New targets in rheumatic diseases, including ankylosing spondylitis. Current rheumatology reports, 20(5), 1-8.‏
• Miyara, M., & Sakaguchi, S. (2007). Natural regulatory T cells: mechanisms of suppression. Trends in molecular medicine, 13(3), 108-116.‏
• Nicolle, P., Liang, H., Reboussin, E., Rabut, G., Warcoin, E., Brignole-Baudouin, F., ... & Reaux-Le Goazigo, A. (2018). Proinflammatory markers, chemokines, and enkephalin in patients suffering from dry eye disease. International journal of molecular sciences, 19(4), 1221.‏
• Parkin, J., & Cohen, B. (2001). An overview of the immune system. The Lancet, 357(9270), 1777-1789.‏
• Pflugfelder, S. C. (2004). Antiinflammatory therapy for dry eye. American journal of ophthalmology, 137(2), 337-342.‏
• Rao, S. K., Mohan, R., Gokhale, N., Matalia, H., & Mehta, P. (2022). Inflammation and dry eye disease—where are we?. International Journal of Ophthalmology, 15(5), 820.‏
• Rolando, M., & Merayo-Lloves, J. (2022). Management Strategies for Evaporative Dry Eye Disease and Future Perspective. Current Eye Research, 1-11.‏
• Rouen, P. A., & White, M. L. (2018). Dry eye disease: prevalence, assessment, and management. Home healthcare now, 36(2), 74-83.‏
• Scheinecker, C., Göschl, L., & Bonelli, M. (2020). Treg cells in health and autoimmune diseases: new insights from single cell analysis. Journal of autoimmunity, 110, 102376.‏
• Stern, M. E., Schaumburg, C. S., & Pflugfelder, S. C. (2013). Dry eye as a mucosal autoimmune disease. International reviews of immunology, 32(1), 19-41.‏
• Su, Z. J., Yu, X. P., Guo, R. Y., Ming, D. S., Huang, L. Y., Su, M. L., ... & Lin, Z. Z. (2013). Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B. Diagnostic microbiology and infectious disease, 76(4), 437-444.‏
• Taniki, N., Nakamoto, N., Chu, P. S., Ichikawa, M., Teratani, T., & Kanai, T. (2022, February). Th17 cells in the liver: balancing autoimmunity and pathogen defense. In Seminars in Immunopathology (pp. 1-18). Springer Berlin Heidelberg.‏
• Widjaja-Adhi, M. A. K., Chao, K., & Golczak, M. (2022). Mouse models in studies on the etiology of evaporative dry eye disease. Experimental Eye Research, 109072.‏
• Wu, B., & Wan, Y. (2020). Molecular control of pathogenic Th17 cells in autoimmune diseases. International immunopharmacology, 80, 106187.‏
• Wu, R., Li, N., Zhao, X., Ding, T., Xue, H., Gao, C., ... & Wang, C. (2020). Low-dose Interleukin-2: Biology and therapeutic prospects in rheumatoid arthritis. Autoimmunity Reviews, 19(10), 102645.‏
• Yamaguchi, T. (2018). Inflammatory response in dry eye. Investigative ophthalmology & visual science, 59(14), DES192-DES199.‏
• Yan, J. B., Luo, M. M., Chen, Z. Y., & He, B. H. (2020). The function and role of the Th17/Treg cell balance in inflammatory bowel disease. Journal of Immunology Research, 2020.‏
• Yang, J., Yang, X., Zou, H., & Li, M. (2016). Oxidative stress and Treg and Th17 dysfunction in systemic lupus erythematosus. Oxidative Medicine and Cellular Longevity, 2016.
• Zhang, S., Gang, X., Yang, S., Cui, M., Sun, L., Li, Z., & Wang, G. (2021). The alterations in and the role of the Th17/Treg balance in metabolic diseases. Frontiers in Immunology, 2702.‏
• Zhang, X., Jeyalatha M, V., Qu, Y., He, X., Ou, S., Bu, J., ... & Li, W. (2017). Dry eye management: targeting the ocular surface microenvironment. International journal of molecular sciences, 18(7), 1398.‏
• Zhang, X., Olsen, N., & Zheng, S. G. (2020). The progress and prospect of regulatory T cells in autoimmune diseases. Journal of Autoimmunity, 111, 102461.‏
• Zhu, L., Hua, F., Ding, W., Ding, K., Zhang, Y., & Xu, C. (2020). The correlation between the Th17/Treg cell balance and bone health. Immunity & Ageing, 17(1), 1-10.‏